reports
Nyrstar NV – Update regarding the judgment of the indictment chamber i...
Nyrstar NV – Update regarding the judgment of the indictment chamber in Brussels dated 5 March 2025 Regulated information – inside information Nyrstar NV – Update regarding the judgment of the indictment chamber in Brussels dated 5 March 2025 21 March 2025 at 07.00 CET Nyrstar NV (“Nyrstar”, or the “Company”) today provides an additional update regarding the criminal proceedings in Brussels. As communicated in a press release dated 5 March 2025 (see ), the indictment chamber of the Brussels court of appeal dismissed the Company from prosecution in a judgment of that day. The FSMA has ...
Nyrstar NV – Update m.b.t. het arrest van de Kamer van Inbeschuldiging...
Nyrstar NV – Update m.b.t. het arrest van de Kamer van Inbeschuldigingstelling te Brussel van 5 maart 2025 Gereglemeteerde informatie – voorwetenschap Nyrstar NV – Update m.b.t. het arrest van de Kamer van Inbeschuldigingstelling te Brussel van 5 maart 2025 21 maart 2025 om 07.00 CET Nyrstar NV (“Nyrstar”, of de “Vennootschap”) geeft vandaag een aanvullende update over de strafprocedure in Brussel. Zoals meegedeeld in een persbericht van 5 maart 2025 (zie ook ), heeft de kamer van inbeschuldigingstelling van het hof van beroep te Brussel de Vennootschap bij arrest van die datum buiten ...
argenx Highlights FcRn Leadership with Long-term Data and Transformati...
argenx Highlights FcRn Leadership with Long-term Data and Transformational Patient Outcomes at the American Academy of Neurology 2025 Annual Meeting Largest safety data set on FcRn blocking demonstrates consistent, favorable safety profile of VYVGART and VYVGART HytrulogMG patients on VYVGART achieve rapid, substantial, and sustained efficacy across multiple dosing regimens, supporting individualized treatment approachADHERE+ oral presentation builds upon evidence of VYVGART Hytrulo driving improved functional ability in CIDP Amsterdam, the Netherlands – March 7, 2025 – argenx SE (Eurone...
Nyrstar NV – Indictment chamber in Brussels dismisses Nyrstar from pro...
Nyrstar NV – Indictment chamber in Brussels dismisses Nyrstar from prosecution Regulated information – inside information Nyrstar NV – Indictment chamber in Brussels dismisses Nyrstar from prosecution 5 March 2025 at 22.30 CET Nyrstar (“the Company”) today provides an update on the criminal proceedings in Brussels. In a judgment dated 5 March 2025, the indictment chamber of the Brussels court of appeal dismissed the Company from prosecution. These proceedings stem from the judicial investigation in Brussels initiated in 2019 following a civil party complaint. The Company previously an...
Nyrstar NV – Kamer van inbeschuldigingstelling te Brussel stelt Nyrsta...
Nyrstar NV – Kamer van inbeschuldigingstelling te Brussel stelt Nyrstar buiten vervolging Gereglementeerde informatie – voorwetenschap Nyrstar NV – Kamer van inbeschuldigingstelling te Brussel stelt Nyrstar buiten vervolging 5 maart 2025 om 22.30 CET Nyrstar (“de Vennootschap”) verstrekt vandaag een update over de strafprocedure in Brussel. In een arrest van 5 maart 2025 heeft de kamer van inbeschuldigingstelling van het hof van beroep te Brussel de Vennootschap buiten vervolging gesteld. Deze strafprocedure is het gevolg van het gerechtelijk onderzoek dat in 2019 in Brussel was inges...
- Aaron Brodjanac
- Baptiste Salaville
- Chaima Ferrandon
- Charlotte Vaisse
- Marc Lavaud
- Sven Edelfelt
- Thomas Zlowodzki
1COV COVESTRO AG
VIE VEOLIA ENVIRONNEMENT SA
PEO BANK POLSKA KASA OPIEKI SA
TKA THYSSENKRUPP AG
RR. ROLLS-ROYCE HOLDINGS PLC
ENGI ENGIE SA.
EDP EDP-ENERGIAS DE PORTUGAL SA
MT ARCELORMITTAL SA
BEKB BEKAERT SA
AAL ANGLO AMERICAN PLC
SLB.N SCHLUMBERGER NV
APAML APERAM SA
OUT1V OUTOKUMPU OYJ
SK SEB SA
GTT GAZTRANSPORT & TECHNIGAZ SA
SSAB A SSAB AB CLASS A
FGR EIFFAGE SA
LSEG LONDON STOCK EXCHANGE GROUP PLC
AGS AGEAS SA/NV
SZG SALZGITTER AG
BEI BEIERSDORF AG
VOE VOESTALPINE AG
EOAN E.ON SE
ACX ACERINOX SA
ENI ENI S.P.A.
GRF GRIFOLS S.A. CLASS A
GEBN GEBERIT AG
ERA ERAMET SA
UCB UCB S.A.
DTE DEUTSCHE TELEKOM AG
P2F PETROFAC LIMITED
CRG CRH PLC
TUB TUBACEX S.A.
SOC SUBSEA 7 S.A.
NDA AURUBIS AG
FCC FOMENTO DE CONSTRUCCIONES Y CONTRATAS S.A.
PKN POLSKI KONCERN NAFTOWY ORLEN S.A.
SBO SCHOELLER-BLECKMANN OILFIELD EQUIPMENT AG
AMG AMG ADVANCED METALLURGICAL GROUP N.V.
EDW EDP RENOVAVEIS SA
KGX KION GROUP AG
TGS TGS-NOPEC GEOPHYSICAL COMPANY ASA
PRY PRYSMIAN S.P.A.
RACE FERRARI NV
TRE TECNICAS REUNIDAS SA
GRF.P GRIFOLS S.A. PREF CLASS B
RIO RIO TINTO PLC
TEC TECHNIPFMC PLC
BHP BHP GROUP LTD
BP. BP P.L.C.
PIRC PIRELLI & C. S.P.A.
ARGX ARGEN-X SE
AMAG AMAG AUSTRIA METALL AG
AKZA AKZO NOBEL N.V.
CPR DAVIDE CAMPARI-MILANO N.V.
VK VALLOUREC SA
STLA STELLANTIS N.V.
TE TECHNIP ENERGIES NV
CTPNV CTP NV
SPM SAIPEM S.P.A.
TEN TENARIS S.A.
SYENS SYENSQO
VIRI VIRIDIEN
- Aaron Brodjanac
- Baptiste Salaville
- Chaima Ferrandon
- Charlotte Vaisse
- Marc Lavaud
- Sven Edelfelt
- Thomas Zlowodzki
1COV COVESTRO AG
VIE VEOLIA ENVIRONNEMENT SA
PEO BANK POLSKA KASA OPIEKI SA
TKA THYSSENKRUPP AG
RR. ROLLS-ROYCE HOLDINGS PLC
ENGI ENGIE SA.
EDP EDP-ENERGIAS DE PORTUGAL SA
MT ARCELORMITTAL SA
BEKB BEKAERT SA
AAL ANGLO AMERICAN PLC
SLB.N SCHLUMBERGER NV
APAML APERAM SA
OUT1V OUTOKUMPU OYJ
SK SEB SA
GTT GAZTRANSPORT & TECHNIGAZ SA
SSAB A SSAB AB CLASS A
FGR EIFFAGE SA
LSEG LONDON STOCK EXCHANGE GROUP PLC
AGS AGEAS SA/NV
SZG SALZGITTER AG
BEI BEIERSDORF AG
VOE VOESTALPINE AG
EOAN E.ON SE
ACX ACERINOX SA
ENI ENI S.P.A.
GRF GRIFOLS S.A. CLASS A
GEBN GEBERIT AG
ERA ERAMET SA
UCB UCB S.A.
DTE DEUTSCHE TELEKOM AG
P2F PETROFAC LIMITED
CRG CRH PLC
TUB TUBACEX S.A.
SOC SUBSEA 7 S.A.
NDA AURUBIS AG
FCC FOMENTO DE CONSTRUCCIONES Y CONTRATAS S.A.
PKN POLSKI KONCERN NAFTOWY ORLEN S.A.
SBO SCHOELLER-BLECKMANN OILFIELD EQUIPMENT AG
AMG AMG ADVANCED METALLURGICAL GROUP N.V.
EDW EDP RENOVAVEIS SA
TGS TGS-NOPEC GEOPHYSICAL COMPANY ASA
PRY PRYSMIAN S.P.A.
RACE FERRARI NV
TRE TECNICAS REUNIDAS SA
GRF.P GRIFOLS S.A. PREF CLASS B
RIO RIO TINTO PLC
TEC TECHNIPFMC PLC
BHP BHP GROUP LTD
BP. BP P.L.C.
PIRC PIRELLI & C. S.P.A.
ARGX ARGEN-X SE
AMAG AMAG AUSTRIA METALL AG
AKZA AKZO NOBEL N.V.
CPR DAVIDE CAMPARI-MILANO N.V.
VK VALLOUREC SA
STLA STELLANTIS N.V.
TE TECHNIP ENERGIES NV
CTPNV CTP NV
SPM SAIPEM S.P.A.
TEN TENARIS S.A.
SYENS SYENSQO
VIRI VIRIDIEN
- Damien Choplain
- Martial Descoutures
- Damien Choplain
- Martial Descoutures
- Guy Sips
- Hilde Van Boxstael
- Kristof Samoy
- Michiel Declercq
- Thomas Couvreur
- Thomas Vranken
- Wim Hoste
- Wim Lewi
- Thomas Vranken
argenx FIRST LOOK: FY24 results highlight transition to sustainable pr...
argenx reported its FY24 financial results, underscoring Vyvgart's sustained commercial momentum and the company's pivot toward sustainable profitability. Despite increasing competition, we see no signs of stopping. For 2025, we mainly look forward to Vyvgart's ramp-up in CIDP, its PFS approval (PDUFA April 10), a PoC readout in LN and ARGX-119's first clinical results in CMS. We maintain our € 670 TP and Accumulate rating.
argenx Reports Full Year 2024 Financial Results and Provides Fourth Qu...
argenx Reports Full Year 2024 Financial Results and Provides Fourth Quarter Business Update $737 million in fourth quarter and $2.2 billion in full year global product net sales Received positive CHMP recommendation for VYVGART pre-filled syringe for gMG, enabling launch in the EU; FDA PDUFA (gMG and CIDP) on track for April 10 10 Phase 3 and 10 Phase 2 studies across pipeline ongoing in 2025, positioning for next wave of growth Recognized one-time tax benefit of $725 million related to previously unrecognized deferred tax assets Management to host conference call today at 2:30 PM CET...
argenx to Present at TD Cowen 45th Annual Healthcare Conference
argenx to Present at TD Cowen 45th Annual Healthcare Conference February 25, 2025Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that Tim Van Hauwermeiren, Chief Executive Officer, will present at the TD Cowen 45th Annual Healthcare Conference on Monday, March 3, 2025 at 11:50 a.m. ET. A live webcast of the presentation may be accessed on the Investors section of the argenx website at . A replay of the webcast will be available on the argenx websi...
argenx to Report Full Year 2024 Financial Results and Fourth Quarter B...
argenx to Report Full Year 2024 Financial Results and Fourth Quarter Business Update on February 27, 2025 February 20, 2025Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that it will host a conference call and audio webcast on Thursday, February 27, 2025 at 2:30 PM CET (8:30 AM ET) to discuss its full year 2024 financial results and provide a fourth quarter business update. A webcast of the live call may be accessed on the Investors section of th...
Nyrstar NV – Update in respect of dissolution or continuation of the C...
Nyrstar NV – Update in respect of dissolution or continuation of the Company Regulated information Nyrstar NV – Update in respect of dissolution or continuation of the Company 6 February 2025 at 18.00 CET In a press release of 2 May 2024 (), the Company announced that it would not submit the dissolution or continuation of the Company to the general meeting at that time and that it would revert to this matter at the earliest after a decision by the Antwerp Commercial Court, Turnhout division on the petition for interim measures filed by certain minority shareholders on 11 March 2024. A...
Argen X SE: 1 director
A director at Argen X SE sold 9,950 shares at 624.000EUR and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sho...
- Bruno Cavalier
- Stephane Houri
IPS IPSOS
LHA DEUTSCHE LUFTHANSA AKTIENGESELLSCHAFT
GET GETLINK SE
FRA FRAPORT AG
ELIOR ELIOR GROUP SA
DG VINCI SA
ALESK ESKER SA
BEKB BEKAERT SA
DB1 DEUTSCHE BOERSE AG
MC LVMH MOET HENNESSY LOUIS VUITTON SE
LI KLEPIERRE SA
COV COVIVIO SA
FGR EIFFAGE SA
UHR SWATCH GROUP LTD. BEARER
RMS HERMES INTERNATIONAL SCA
SBMO SBM OFFSHORE NV
MF WENDEL SE
EN BOUYGUES SA
STF STEF
INF INFOTEL SA
SCR SCOR SE
DEC JCDECAUX SA
ASY ASSYSTEM SA
EL ESSILORLUXOTTICA SA
IAG INTERNATIONAL CONSOLIDATED AIRLINES GROUP SA
PSM PROSIEBENSAT.1 MEDIA SE
COLR ETABLISSEMENTEN FRANZ COLRUYT N.V.
BRBY BURBERRY GROUP PLC
FII LISI SA
GOE GROUPE GORGE SA
KER KERING SA
ALTA ALTAREA SCA
VNA VONOVIA SE
ZAL ZALANDO SE
ERA ERAMET SA
ICAD ICADE SA
01913 PRADA S.P.A.
IMPN IMPLENIA AG
REP REPSOL SA
COR CORTICEIRA AMORIM SGPS SA
RAA RATIONAL AG
DOKA DORMAKABA HOLDING AG
DLG DE'LONGHI S.P.A.
ELI ELIA GROUP SA/NV
MONC MONCLER SPA
ONTEX ONTEX GROUP N.V.
BC BRUNELLO CUCINELLI S.P.A.
CFR COMPAGNIE FINANCIERE RICHEMONT SA
COL INMOBILIARIA COLONIAL SOCIMI SA
CSM CORBION NV
COFA COFACE SA
HBH HORNBACH HOLDING AG & CO. KGAA
XFAB X-FAB SILICON FOUNDRIES SE
ARGX ARGEN-X SE
JEN JENOPTIK AG
VRLA VERALLIA SAS
ALG ALLEGRO.EU SA
INPST INPOST S.A.
FPE3 FUCHS PETROLUB SE
ALAFY AFYREN
AM DASSAULT AVIATION
CTPNV CTP NV
EAPI EUROAPI
DEME DEME GROUP NV
FLE PEGASUS ENTREPRENEURIAL ACQUISITION CO EURO BV
SHUR SHURGARD SELF STORAGE LIMITED
AF AIR FRANCE - KLM
VIRI VIRIDIEN
CAN CANAL+
- Damien Choplain
- Martial Descoutures
- Bruno Cavalier
- Jean Danjou
- Guy Sips
- Hilde Van Boxstael
- Sharad Kumar S.P
- Thomas Vranken
- Wim Lewi
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.